Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-08

Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy [Phase 3]

View source ↗

Summary

This Phase 3 study assessed the effectiveness and safety of topiramate in children with epilepsy and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy, Epilepsies, Partial | Phase 3 | Status: COMPLETED